Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales for COVID

by | Apr 29, 2025 | Stock Market

Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.”

Article Attribution | Read More at Article Source